Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.69 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.61 |
| ▸ | AR | P10275 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.51 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.51 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.51 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390734 | 1.00 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL4354346 | 0.98 | ALDH1A1 (0.67) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL30619938 | 0.89 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL28184430 | 0.89 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL11059996 | 0.86 | KCNH2 (0.67) | ALDH1A1KDM4EHPGDHSD17B10KCNH2 | |
| SCHEMBL1124002 | 0.86 | HPGD (0.60) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL1123454 | 0.86 | HPGD (0.60) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL21353591 | 0.85 | — | — | |
| SCHEMBL29857922 | 0.85 | PLD1 (0.73) | ALDH1A1KDM4EHPGDHSD17B10PLD1 | |
| SCHEMBL15800694 | 0.85 | PLD1 (0.73) | ALDH1A1KDM4EHPGDHSD17B10PLD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080791-A | Construction of 1, 3-dioxolane derivatives by catalyzing electron-deficient alkenyl ethylene oxide through Lewis base | 山东第一医科大学(山东省医学科学院) | 2024-12-06 | — | — | CN | claimed |
| CN-119059965-A | Continuous synthesis method of 4- (pyridine-2-yl) morpholine | 深圳智微通科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118904863-A | Recycling method of polyester cotton spandex blended fabric | 青岛阿脒诺材料技术有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118893071-A | Method for recycling polyester cotton blended fabric | 青岛阿脒诺材料技术有限公司 | 2024-11-05 | — | — | CN | claimed |
| WO-2023225776-A1 | METHOD FOR PREPARING HIGHLY SENSITIVE AND STABLE CHEMILUMINESCENT SUBSTRATE LIQUID AND USE THEREOF IN IMMUNOASSAY | 孙嘉怡 | 2023-11-30 | — | — | WO | claimed |
| EP-4081299-A1 | DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES | UCB Biopharma SRL (BE) | 2022-11-02 | — | — | EP | claimed |
| CN-109810806-B | Flame-retardant electronic cleaning agent and preparation method thereof | 普信氟硅新材料（衢州）有限公司 | 2021-08-10 | — | — | CN | claimed |
| CN-112608355-A | Preparation method of tetraacetylglucose | 北京悦康科创医药科技股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| CN-109553591-B | Preparation method of quetiapine fumarate intermediate | 山东安信制药有限公司 | 2020-12-15 | — | — | CN | claimed |
| EP-3728386-A1 | METHOD FOR PRODUCING A COMPOSITION COMPRISING A POLYURETHANE WITH NCO END GROUPS | BOSTIK SA (FR) | 2020-10-28 | — | — | EP | claimed |
| US-20020077321-A1 | Cycloalkyl alkanoic acids as integrin receptor antagonists | PHARMACIA CORPORATION | 2002-06-20 | — | — | US | claimed |
| WO-2002018340-A1 | GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS | PHARMACIA CORPORATION (US) | 2002-03-07 | — | — | WO | claimed |
| WO-2001096334-A2 | HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS | PHARMACIA CORPORATION (US) | 2001-12-20 | — | — | WO | claimed |
| WO-2001096307-A2 | CYCLOALKYL ALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS | PHARMACIA CORPORATION (US) | 2001-12-20 | — | — | WO | claimed |
| WO-2001096310-A1 | DIHYDROSTILBENE ALKANOIC ACID DERIVATIVES USEFUL AS VITRONECTIN ANTAGONISTS | PHARMACIA CORPORATION (US) | 2001-12-20 | — | — | WO | claimed |
| EP-0442767-B1 | Method and apparatus for treating a natural gas | INST FRANCAIS DU PETROLE (FR) | 1994-07-20 | — | — | EP | claimed |
| CN-1041586-A | The preparation method of nitro-phenyl-dihydropyridine amides base | BAYER AG (DE) | 1990-04-25 | — | — | CN | claimed |
| EP-0138153-B1 | A SELECTIVE ACYLATION PROCESS | AB LEO (SE) | 1988-11-23 | — | — | EP | claimed |
| US-4592869-A | Selective acylation process | AKTIEBOLAGET LEO (SE) | 1986-06-03 | — | — | US | claimed |
| EP-0138153-A2 | A selective acylation process | AB LEO (SE) | 1985-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077321-A1 | Cycloalkyl alkanoic acids as integrin receptor antagonists | ITGA5, ITGB5, ITGB3 | ALDH1A1 552/4885KDM4E 3035/4885HPGD 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.